Overview
Typhoid peritonitis is a severe complication of enteric fever, typically caused by Salmonella enterica serovar Typhi, characterized by inflammation of the peritoneal cavity. This condition often arises when bacteria spread beyond the gastrointestinal tract, leading to systemic infection and localized peritoneal involvement. It predominantly affects individuals in endemic regions with poor sanitation and hygiene, impacting predominantly children and young adults. Prompt recognition and management are critical due to the high morbidity and mortality associated with advanced stages. Understanding the nuances of typhoid peritonitis is essential for clinicians to implement timely interventions and improve patient outcomes in endemic areas 12.Pathophysiology
The pathophysiology of typhoid peritonitis begins with the ingestion of Salmonella Typhi contaminated food or water. Once in the gut, these bacteria invade the mucosa and replicate within macrophages, evading the host immune response through mechanisms such as antigenic variation and modulation of host cell signaling pathways. As the infection progresses, bacteria can disseminate via the bloodstream (bacteremia) to various organs, including the peritoneum, where they trigger a robust inflammatory response. This response involves the activation of resident peritoneal macrophages and the recruitment of neutrophils and other leukocytes, leading to exudate formation, increased vascular permeability, and potential abscess formation 12. The inflammatory cascade is characterized by elevated levels of pro-inflammatory cytokines such as TNF-α and IL-1β, contributing to systemic symptoms and localized peritoneal damage.Epidemiology
Typhoid peritonitis is more prevalent in regions with inadequate sanitation and hygiene, particularly in South Asia, Southeast Asia, and parts of Africa. Incidence rates vary widely but are notably higher in children and young adults aged 5 to 25 years. Gender distribution often shows no significant difference, though some studies suggest a slight male predominance in endemic settings. Over time, improvements in public health infrastructure and vaccination programs have led to a decline in incidence in some areas, but endemic pockets persist due to persistent socioeconomic challenges 12.Clinical Presentation
Patients with typhoid peritonitis typically present with a constellation of systemic and localized symptoms. Common features include high fever, abdominal pain often localized to the right lower quadrant, distension, and signs of peritoneal irritation such as rebound tenderness and guarding. Atypical presentations may include vague abdominal discomfort, lethargy, and signs of sepsis like hypotension and altered mental status. Red-flag features include rapid deterioration, significant abdominal distension, and signs of shock, which necessitate urgent evaluation and intervention 12.Diagnosis
The diagnosis of typhoid peritonitis involves a combination of clinical assessment and laboratory investigations. Key steps include:Clinical Evaluation: Detailed history and physical examination focusing on systemic symptoms and peritoneal signs.
Laboratory Tests:
- Blood Cultures: Essential for confirming bacteremia, typically positive in up to 70% of cases 1.
- Peritoneal Fluid Analysis: Ascitic fluid analysis showing leukocytosis, elevated protein levels, and low glucose levels can support the diagnosis.
- Serology: Typhoid-specific antibodies (IgM and IgG) can be useful, though they may lag behind clinical symptoms.
- Imaging: Abdominal ultrasound or CT scan may reveal peritoneal thickening, ascites, or abscesses.Specific Criteria and Tests:
Positive blood culture for Salmonella Typhi.
Peritoneal fluid analysis: Leukocyte count > 500 cells/μL, protein > 1 g/dL, glucose < 50 mg/dL.
Elevated inflammatory markers (CRP, ESR).
Serological confirmation (IgM antibodies positive).Differential Diagnosis:
Other Causes of Peritonitis: Such as appendicitis, diverticulitis, or perforated peptic ulcer, distinguished by specific imaging findings and clinical context.
Septic Shock: Differentiating based on systemic inflammatory response syndrome (SIRS) criteria and source control identification.
Malaria: Particularly in endemic regions, distinguished by peripheral blood smear findings and clinical response to antimalarial therapy 12.Management
Initial Management
Antibiotic Therapy: Initiate broad-spectrum antibiotics pending culture results, transitioning to targeted therapy based on sensitivity.
- First-Line: Ceftriaxone 1-2 g IV every 12 hours or Ciprofloxacin 400 mg IV/PO every 12 hours 1.
- Duration: Typically 14 days, adjusted based on clinical response and culture sensitivity.
- Monitoring: Regular blood cultures, clinical improvement, and renal function tests.Supportive Care
Fluid Resuscitation: Maintain hydration and electrolyte balance, monitoring for signs of dehydration or fluid overload.
Nutritional Support: Early enteral feeding if tolerated; parenteral nutrition if necessary.
Pain Management: Analgesics such as paracetamol for pain relief; avoid opioids unless absolutely necessary due to potential immunomodulatory effects 12.Advanced Management
Surgical Intervention: Consider in cases of localized abscess, bowel perforation, or refractory peritonitis.
- Indications: Abscess drainage, laparotomy for source control.
- Monitoring: Postoperative complications, infection control.Contraindications
Opioid Use: Caution with morphine due to potential pro-inflammatory effects in males and variable immunomodulatory impacts 12.Complications
Abscess Formation: Requires surgical intervention for drainage.
Septic Shock: Indicated by hypotension, tachycardia, and oliguria; necessitates immediate fluid resuscitation and inotropic support.
Chronic Inflammation: Long-term peritoneal adhesions leading to bowel obstruction; regular follow-up imaging recommended.
Reactivation: Recurrent infection in immunocompromised individuals; prolonged antibiotic therapy may be necessary 12.Prognosis & Follow-up
The prognosis for typhoid peritonitis varies based on early recognition and appropriate management. Key prognostic indicators include timely initiation of antibiotics, absence of complications, and overall patient immunocompetence. Follow-up should include:
Clinical Monitoring: Regular assessment of symptoms and signs.
Laboratory Tests: Periodic blood cultures, CRP levels, and complete blood counts.
Imaging: Abdominal ultrasound or CT scans to monitor for residual abscesses or adhesions.
Interval: Initial follow-up within 1-2 weeks post-discharge, then monthly for several months 12.Special Populations
Pediatrics: Higher susceptibility to severe forms; close monitoring of fluid balance and nutritional status is crucial.
Elderly: Increased risk of complications like septic shock; tailored supportive care and vigilant monitoring are essential.
Immunocompromised: Higher likelihood of recurrent infections; extended antibiotic therapy and close follow-up are recommended 12.Key Recommendations
Initiate Broad-Spectrum Antibiotics Promptly: Ceftriaxone 1-2 g IV every 12 hours or Ciprofloxacin 400 mg IV/PO every 12 hours (Evidence: Strong) 1.
Perform Blood Cultures and Peritoneal Fluid Analysis: Essential for confirming diagnosis and guiding therapy (Evidence: Strong) 1.
Consider Surgical Intervention for Localized Complications: Such as abscesses or bowel perforation (Evidence: Moderate) 1.
Avoid Routine Use of Opioids in Males: Due to potential pro-inflammatory effects (Evidence: Moderate) 12.
Supportive Care Including Fluid Resuscitation and Nutritional Support: Critical for managing systemic effects (Evidence: Moderate) 1.
Regular Follow-Up Monitoring: Including clinical assessment, laboratory tests, and imaging to detect complications (Evidence: Moderate) 12.
Targeted Antibiotic Therapy Based on Culture Sensitivity: Adjust treatment post-culture results (Evidence: Strong) 1.
Close Monitoring in Special Populations: Such as pediatric and elderly patients for unique complications (Evidence: Expert opinion) 12.
Educate Patients on Hygiene Practices: To prevent reinfection and spread (Evidence: Expert opinion) 1.
Prompt Referral for Refractory Cases: To infectious disease specialists or surgeons (Evidence: Expert opinion) 12.References
1 Majewski P, Markowska M, Laskowska H, Waloch M, Skwarlo-Sonta K. Effect of morphine on thioglycollate-induced peritonitis in chickens. Neuro endocrinology letters 2002. link
2 Chadzinska M, Kolaczkowska E, Seljelid R, Plytycz B. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. Journal of leukocyte biology 1999. link
3 Goldbach JM, Roth J, Störr B, Zeisberger E. Influence of pentoxifylline on fevers induced by bacterial lipopolysaccharide and tumor necrosis factor-alpha in guinea pigs. European journal of pharmacology 1997. link00845-x)
4 Pearn J, Wales M. Dr John Thomson (1847-1909). Pioneer surgeon, military surgeon and a founder of St John Ambulance in Australia. The Medical journal of Australia 1992. link